Healthy Living - November 2nd
Healthy Living
00:00
Major Breakthrough for Ulcerative Colitis
Ross reviews the LUCENT-3 trial showing mirikizumab induces sustained remission in many moderate-to-severe ulcerative colitis patients.
Play episode from 01:21:57
Transcript
